TementInformed written consent was obtained from each participant and the trial was approved by ethics committees in Uganda, Zimbabwe and the UK. DART was a randomised controlled trial comparing routine Laboratory (CD4 and toxicity) plus Clinical Monitoring (LCM) with CDM in 3316 symptomatic (WHO stage 2/3/4) HIV?infected ART-naive adults initiating combination ART with in Uganda/Zimbabwe CD4,200